Global Transdermal and Transmucosal Drug Delivery Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 280280
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Transdermal and Transmucosal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Transdermal and Transmucosal Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinics accounting for % of the Transdermal and Transmucosal Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transdermal Drug Delivery segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Transdermal and Transmucosal Drug Delivery include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, and DURECT, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Transdermal and Transmucosal Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Transdermal Drug Delivery

Transmucosal Drug Delivery

Market segment by Application, can be divided into

Clinics

Hospitals

Others

Market segment by players, this report covers

3M

Antares Pharma

Aveva Drug Delivery Systems

Corium International

DURECT

Pantec Biosolutions

Tapemark

Tesa Labtec

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Transdermal and Transmucosal Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Transdermal and Transmucosal Drug Delivery, with revenue, gross margin and global market share of Transdermal and Transmucosal Drug Delivery from 2019 to 2022.

Chapter 3, the Transdermal and Transmucosal Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal and Transmucosal Drug Delivery market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Transdermal and Transmucosal Drug Delivery research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Transdermal and Transmucosal Drug Delivery

1.2 Classification of Transdermal and Transmucosal Drug Delivery by Type

1.2.1 Overview: Global Transdermal and Transmucosal Drug Delivery Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Type in 2021

1.2.3 Transdermal Drug Delivery

1.2.4 Transmucosal Drug Delivery

1.3 Global Transdermal and Transmucosal Drug Delivery Market by Application

1.3.1 Overview: Global Transdermal and Transmucosal Drug Delivery Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Clinics

1.3.3 Hospitals

1.3.4 Others

1.4 Global Transdermal and Transmucosal Drug Delivery Market Size & Forecast

1.5 Global Transdermal and Transmucosal Drug Delivery Market Size and Forecast by Region

1.5.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Transdermal and Transmucosal Drug Delivery Market Size by Region, (2017-2022)

1.5.3 North America Transdermal and Transmucosal Drug Delivery Market Size and Prospect (2017-2028)

1.5.4 Europe Transdermal and Transmucosal Drug Delivery Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Transdermal and Transmucosal Drug Delivery Market Size and Prospect (2017-2028)

1.5.6 South America Transdermal and Transmucosal Drug Delivery Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Transdermal and Transmucosal Drug Delivery Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Transdermal and Transmucosal Drug Delivery Market Drivers

1.6.2 Transdermal and Transmucosal Drug Delivery Market Restraints

1.6.3 Transdermal and Transmucosal Drug Delivery Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 3M

2.1.1 3M Details

2.1.2 3M Major Business

2.1.3 3M Transdermal and Transmucosal Drug Delivery Product and Solutions

2.1.4 3M Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 3M Recent Developments and Future Plans

2.2 Antares Pharma

2.2.1 Antares Pharma Details

2.2.2 Antares Pharma Major Business

2.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Product and Solutions

2.2.4 Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Antares Pharma Recent Developments and Future Plans

2.3 Aveva Drug Delivery Systems

2.3.1 Aveva Drug Delivery Systems Details

2.3.2 Aveva Drug Delivery Systems Major Business

2.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Product and Solutions

2.3.4 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Aveva Drug Delivery Systems Recent Developments and Future Plans

2.4 Corium International

2.4.1 Corium International Details

2.4.2 Corium International Major Business

2.4.3 Corium International Transdermal and Transmucosal Drug Delivery Product and Solutions

2.4.4 Corium International Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Corium International Recent Developments and Future Plans

2.5 DURECT

2.5.1 DURECT Details

2.5.2 DURECT Major Business

2.5.3 DURECT Transdermal and Transmucosal Drug Delivery Product and Solutions

2.5.4 DURECT Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 DURECT Recent Developments and Future Plans

2.6 Pantec Biosolutions

2.6.1 Pantec Biosolutions Details

2.6.2 Pantec Biosolutions Major Business

2.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Product and Solutions

2.6.4 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Pantec Biosolutions Recent Developments and Future Plans

2.7 Tapemark

2.7.1 Tapemark Details

2.7.2 Tapemark Major Business

2.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Product and Solutions

2.7.4 Tapemark Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Tapemark Recent Developments and Future Plans

2.8 Tesa Labtec

2.8.1 Tesa Labtec Details

2.8.2 Tesa Labtec Major Business

2.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Product and Solutions

2.8.4 Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Tesa Labtec Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Transdermal and Transmucosal Drug Delivery Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Transdermal and Transmucosal Drug Delivery Players Market Share in 2021

3.2.2 Top 10 Transdermal and Transmucosal Drug Delivery Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Transdermal and Transmucosal Drug Delivery Players Head Office, Products and Services Provided

3.4 Transdermal and Transmucosal Drug Delivery Mergers & Acquisitions

3.5 Transdermal and Transmucosal Drug Delivery New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Transdermal and Transmucosal Drug Delivery Revenue and Market Share by Type (2017-2022)

4.2 Global Transdermal and Transmucosal Drug Delivery Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Application (2017-2022)

5.2 Global Transdermal and Transmucosal Drug Delivery Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2028)

6.2 North America Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2028)

6.3 North America Transdermal and Transmucosal Drug Delivery Market Size by Country

6.3.1 North America Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2028)

6.3.2 United States Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

6.3.3 Canada Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

6.3.4 Mexico Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2028)

7.2 Europe Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2028)

7.3 Europe Transdermal and Transmucosal Drug Delivery Market Size by Country

7.3.1 Europe Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2028)

7.3.2 Germany Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

7.3.3 France Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

7.3.5 Russia Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

7.3.6 Italy Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2028)

8.2 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2028)

8.3 Asia-Pacific Transdermal and Transmucosal Drug Delivery Market Size by Region

8.3.1 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Region (2017-2028)

8.3.2 China Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

8.3.3 Japan Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

8.3.4 South Korea Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

8.3.5 India Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

8.3.7 Australia Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2028)

9.2 South America Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2028)

9.3 South America Transdermal and Transmucosal Drug Delivery Market Size by Country

9.3.1 South America Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2028)

9.3.2 Brazil Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

9.3.3 Argentina Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2028)

10.2 Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2028)

10.3 Middle East & Africa Transdermal and Transmucosal Drug Delivery Market Size by Country

10.3.1 Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2028)

10.3.2 Turkey Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

10.3.4 UAE Transdermal and Transmucosal Drug Delivery Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Transdermal and Transmucosal Drug Delivery Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Transdermal and Transmucosal Drug Delivery Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Transdermal and Transmucosal Drug Delivery Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Transdermal and Transmucosal Drug Delivery Revenue (USD Million) by Region (2017-2022)

Table 5. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Region (2023-2028)

Table 6. 3M Corporate Information, Head Office, and Major Competitors

Table 7. 3M Major Business

Table 8. 3M Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 9. 3M Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Antares Pharma Corporate Information, Head Office, and Major Competitors

Table 11. Antares Pharma Major Business

Table 12. Antares Pharma Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 13. Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Aveva Drug Delivery Systems Corporate Information, Head Office, and Major Competitors

Table 15. Aveva Drug Delivery Systems Major Business

Table 16. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 17. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Corium International Corporate Information, Head Office, and Major Competitors

Table 19. Corium International Major Business

Table 20. Corium International Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 21. Corium International Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. DURECT Corporate Information, Head Office, and Major Competitors

Table 23. DURECT Major Business

Table 24. DURECT Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 25. DURECT Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Pantec Biosolutions Corporate Information, Head Office, and Major Competitors

Table 27. Pantec Biosolutions Major Business

Table 28. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 29. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Tapemark Corporate Information, Head Office, and Major Competitors

Table 31. Tapemark Major Business

Table 32. Tapemark Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 33. Tapemark Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Tesa Labtec Corporate Information, Head Office, and Major Competitors

Table 35. Tesa Labtec Major Business

Table 36. Tesa Labtec Transdermal and Transmucosal Drug Delivery Product and Solutions

Table 37. Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Global Transdermal and Transmucosal Drug Delivery Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 39. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 40. Breakdown of Transdermal and Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)

Table 41. Transdermal and Transmucosal Drug Delivery Players Head Office, Products and Services Provided

Table 42. Transdermal and Transmucosal Drug Delivery Mergers & Acquisitions in the Past Five Years

Table 43. Transdermal and Transmucosal Drug Delivery New Entrants and Expansion Plans

Table 44. Global Transdermal and Transmucosal Drug Delivery Revenue (USD Million) by Type (2017-2022)

Table 45. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Type (2017-2022)

Table 46. Global Transdermal and Transmucosal Drug Delivery Revenue Forecast by Type (2023-2028)

Table 47. Global Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2022)

Table 48. Global Transdermal and Transmucosal Drug Delivery Revenue Forecast by Application (2023-2028)

Table 49. North America Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2022) & (USD Million)

Table 50. North America Transdermal and Transmucosal Drug Delivery Revenue by Type (2023-2028) & (USD Million)

Table 51. North America Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2022) & (USD Million)

Table 52. North America Transdermal and Transmucosal Drug Delivery Revenue by Application (2023-2028) & (USD Million)

Table 53. North America Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2022) & (USD Million)

Table 54. North America Transdermal and Transmucosal Drug Delivery Revenue by Country (2023-2028) & (USD Million)

Table 55. Europe Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2022) & (USD Million)

Table 56. Europe Transdermal and Transmucosal Drug Delivery Revenue by Type (2023-2028) & (USD Million)

Table 57. Europe Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2022) & (USD Million)

Table 58. Europe Transdermal and Transmucosal Drug Delivery Revenue by Application (2023-2028) & (USD Million)

Table 59. Europe Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2022) & (USD Million)

Table 60. Europe Transdermal and Transmucosal Drug Delivery Revenue by Country (2023-2028) & (USD Million)

Table 61. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2022) & (USD Million)

Table 62. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Type (2023-2028) & (USD Million)

Table 63. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2022) & (USD Million)

Table 64. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Application (2023-2028) & (USD Million)

Table 65. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Region (2017-2022) & (USD Million)

Table 66. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Region (2023-2028) & (USD Million)

Table 67. South America Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2022) & (USD Million)

Table 68. South America Transdermal and Transmucosal Drug Delivery Revenue by Type (2023-2028) & (USD Million)

Table 69. South America Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2022) & (USD Million)

Table 70. South America Transdermal and Transmucosal Drug Delivery Revenue by Application (2023-2028) & (USD Million)

Table 71. South America Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2022) & (USD Million)

Table 72. South America Transdermal and Transmucosal Drug Delivery Revenue by Country (2023-2028) & (USD Million)

Table 73. Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Type (2017-2022) & (USD Million)

Table 74. Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Type (2023-2028) & (USD Million)

Table 75. Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Application (2017-2022) & (USD Million)

Table 76. Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Application (2023-2028) & (USD Million)

Table 77. Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Country (2017-2022) & (USD Million)

Table 78. Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Transdermal and Transmucosal Drug Delivery Picture

Figure 2. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Type in 2021

Figure 3. Transdermal Drug Delivery

Figure 4. Transmucosal Drug Delivery

Figure 5. Transdermal and Transmucosal Drug Delivery Revenue Market Share by Application in 2021

Figure 6. Clinics Picture

Figure 7. Hospitals Picture

Figure 8. Others Picture

Figure 9. Global Transdermal and Transmucosal Drug Delivery Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Transdermal and Transmucosal Drug Delivery Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Region (2017-2028)

Figure 12. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Region in 2021

Figure 13. North America Transdermal and Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Transdermal and Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Transdermal and Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Transdermal and Transmucosal Drug Delivery Market Drivers

Figure 19. Transdermal and Transmucosal Drug Delivery Market Restraints

Figure 20. Transdermal and Transmucosal Drug Delivery Market Trends

Figure 21. 3M Recent Developments and Future Plans

Figure 22. Antares Pharma Recent Developments and Future Plans

Figure 23. Aveva Drug Delivery Systems Recent Developments and Future Plans

Figure 24. Corium International Recent Developments and Future Plans

Figure 25. DURECT Recent Developments and Future Plans

Figure 26. Pantec Biosolutions Recent Developments and Future Plans

Figure 27. Tapemark Recent Developments and Future Plans

Figure 28. Tesa Labtec Recent Developments and Future Plans

Figure 29. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Players in 2021

Figure 30. Transdermal and Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 31. Global Top 3 Players Transdermal and Transmucosal Drug Delivery Revenue Market Share in 2021

Figure 32. Global Top 10 Players Transdermal and Transmucosal Drug Delivery Revenue Market Share in 2021

Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 34. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Type in 2021

Figure 35. Global Transdermal and Transmucosal Drug Delivery Market Share Forecast by Type (2023-2028)

Figure 36. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Application in 2021

Figure 37. Global Transdermal and Transmucosal Drug Delivery Market Share Forecast by Application (2023-2028)

Figure 38. North America Transdermal and Transmucosal Drug Delivery Sales Market Share by Type (2017-2028)

Figure 39. North America Transdermal and Transmucosal Drug Delivery Sales Market Share by Application (2017-2028)

Figure 40. North America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Country (2017-2028)

Figure 41. United States Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Transdermal and Transmucosal Drug Delivery Sales Market Share by Type (2017-2028)

Figure 45. Europe Transdermal and Transmucosal Drug Delivery Sales Market Share by Application (2017-2028)

Figure 46. Europe Transdermal and Transmucosal Drug Delivery Revenue Market Share by Country (2017-2028)

Figure 47. Germany Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. France Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. United Kingdom Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Russia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Italy Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Asia-Pacific Transdermal and Transmucosal Drug Delivery Sales Market Share by Type (2017-2028)

Figure 53. Asia-Pacific Transdermal and Transmucosal Drug Delivery Sales Market Share by Application (2017-2028)

Figure 54. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue Market Share by Region (2017-2028)

Figure 55. China Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Japan Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. South Korea Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. India Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Southeast Asia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Australia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South America Transdermal and Transmucosal Drug Delivery Sales Market Share by Type (2017-2028)

Figure 62. South America Transdermal and Transmucosal Drug Delivery Sales Market Share by Application (2017-2028)

Figure 63. South America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Country (2017-2028)

Figure 64. Brazil Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Argentina Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Middle East and Africa Transdermal and Transmucosal Drug Delivery Sales Market Share by Type (2017-2028)

Figure 67. Middle East and Africa Transdermal and Transmucosal Drug Delivery Sales Market Share by Application (2017-2028)

Figure 68. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue Market Share by Country (2017-2028)

Figure 69. Turkey Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Saudi Arabia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. UAE Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Methodology

Figure 73. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz